WRF
ELV icon

Waddell & Reed Financial’s Elevance Health ELV Stock Holding History

Waddell & Reed Financial’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$117M Buy
326,995
+28,402
+10% +$9.13M 0.24% 129
2020
Q4 		$95.9M Buy
298,593
+65,073
+28% +$20M 0.2% 139
2020
Q3 		$62.7M Sell
233,520
-1,353
-0.6% -$364K 0.15% 173
2020
Q2 		$61.8M Buy
234,873
+10,441
+5% +$2.79M 0.16% 164
2020
Q1 		$51M Sell
224,432
-309,565
-58% -$84.4M 0.17% 156
2019
Q4 		$161M Buy
533,997
+72,063
+16% +$19.8M 0.4% 59
2019
Q3 		$111M Buy
461,934
+94,075
+26% +$25.8M 0.29% 100
2019
Q2 		$104M Buy
367,859
+221,631
+152% +$60.5M 0.26% 114
2019
Q1 		$42M Buy
146,228
+1,094
+0.8% +$316K 0.1% 233
2018
Q4 		$38.1M Hold
145,134
– – 0.11% 229
2018
Q3 		$39.8M Buy
145,134
+13,419
+10% +$3.48M 0.09% 263
2018
Q2 		$31.4M Buy
+131,715
New +$30.5M 0.07% 282
2017
Q4 		– Sell
-118,179
Closed -$22.4M – 535
2017
Q3 		$22.4M Sell
118,179
-137,532
-54% -$26.2M 0.05% 317
2017
Q2 		$48.1M Buy
255,711
+9,273
+4% +$1.67M 0.11% 223
2017
Q1 		$40.8M Sell
246,438
-8,880
-3% -$1.41M 0.09% 246
2016
Q4 		$36.7M Sell
255,318
-1,086,952
-81% -$146M 0.08% 258
2016
Q3 		$168M Sell
1,342,270
-1,394,752
-51% -$180M 0.35% 77
2016
Q2 		$359M Buy
2,737,022
+223,516
+9% +$30.6M 0.76% 32
2016
Q1 		$349M Buy
2,513,506
+761,159
+43% +$102M 0.66% 40
2015
Q4 		$244M Buy
1,752,347
+686,547
+64% +$94.6M 0.4% 70
2015
Q3 		$149M Buy
1,065,800
+900,900
+546% +$135M 0.25% 106
2015
Q2 		$27.1M Buy
164,900
+49,400
+43% +$7.89M 0.04% 298
2015
Q1 		$17.8M Sell
115,500
-18,200
-14% -$2.59M 0.02% 359
2014
Q4 		$16.8M Sell
133,700
-67,500
-34% -$8.34M 0.02% 348
2014
Q3 		$24.1M Buy
201,200
+39,300
+24% +$4.51M 0.03% 312
2014
Q2 		$17.4M Buy
+161,900
New +$16.7M 0.03% 360
2013
Q4 		– Sell
-341,715
Closed -$28.6M – 564
2013
Q3 		$28.6M Sell
341,715
-12,500
-4% -$1.07M 0.05% 279
2013
Q2 		$29M Buy
+354,215
New +$26.5M 0.06% 258

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Waddell & Reed Financial's ELV Position: Q1 2021 in Review

Waddell & Reed Financial increased its Elevance Health (ELV) stake by 9.5% in Q1 2021, buying an estimated $9.13M and bringing the position to 326,995 shares worth $117M. The position accounts for 0.24% of the portfolio, ranked #129.

Waddell & Reed Financial first reported a position in ELV in Q2 2013 and has held it in 28 quarters since. The position peaked at $359M in Q2 2016. 1,211 funds tracked by Wall St. Rank hold ELV as of Q1 2021.

  • Waddell & Reed Financial held 326,995 shares of Elevance Health worth $117M as of Q1 2021.
  • Waddell & Reed Financial bought 28,402 Elevance Health shares in Q1 2021, an estimated $9.13M.
  • Elevance Health made up 0.24% of Waddell & Reed Financial's portfolio in Q1 2021, its #129 holding.
  • Waddell & Reed Financial first reported a position in Elevance Health in Q2 2013 and has held it in 28 quarters since.
  • Waddell & Reed Financial's Elevance Health position peaked at $359M in Q2 2016.
  • 1,211 funds tracked by Wall St. Rank held Elevance Health as of Q1 2021.

Based on Waddell & Reed Financial's 13F filing for Q1 2021, filed 12 May 2021.